<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedBookArticle><BookDocument><PMID Version="1">29999865</PMID><ArticleIdList><ArticleId IdType="bookaccession">NBK500806</ArticleId></ArticleIdList><Book><Publisher><PublisherName>National Library of Medicine (US)</PublisherName><PublisherLocation>Bethesda (MD)</PublisherLocation></Publisher><BookTitle book="lactmed">Drugs and Lactation Database (LactMed)</BookTitle><PubDate><Year>2006</Year></PubDate><BeginningDate><Year>2006</Year></BeginningDate><Medium>Internet</Medium></Book><ArticleTitle book="lactmed" part="LM1226">Obiltoxaximab</ArticleTitle><Language>eng</Language><PublicationType UI="D016454">Review</PublicationType><Abstract><AbstractText>No information is available on the clinical use of obiltoxaximab during breastfeeding. Because obiltoxaximab is a large protein molecule with a molecular weight of 148,000, the amount in milk is likely to be very low. It is also likely to be partially destroyed in the infant's gastrointestinal tract and absorption by the infant is probably minimal. Until more data become available, obiltoxaximab should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant.</AbstractText></Abstract><Sections><Section><SectionTitle book="lactmed" part="LM1226" sec="LM1226.Drug_Levels_and_Effects">Drug Levels and Effects</SectionTitle></Section><Section><SectionTitle book="lactmed" part="LM1226" sec="LM1226.Substance_Identification">Substance Identification</SectionTitle></Section></Sections><KeywordList Owner="NLM"><Keyword MajorTopicYN="N">Obiltoxaximab</Keyword><Keyword MajorTopicYN="N">Anthim</Keyword><Keyword MajorTopicYN="N">Obiltoxaximab [USAN]</Keyword><Keyword MajorTopicYN="N">UNII-29Z5DNL48C</Keyword><Keyword MajorTopicYN="N">29Z5DNL48C</Keyword><Keyword MajorTopicYN="N">ETI 204</Keyword><Keyword MajorTopicYN="N">ETI-204</Keyword><Keyword MajorTopicYN="N">1351337-07-9</Keyword><Keyword MajorTopicYN="N">Immunoglobulin G1, anti-(Bacillus anthracis anthrax protective antigen) (human-Mus musculus monoclonal ETI-204 heavy chain), disulfide with human-Mus musculus monoclonal ETI-204 kappa-chain, dimer</Keyword></KeywordList><ContributionDate><Year>2022</Year><Month>5</Month><Day>15</Day></ContributionDate></BookDocument><PubmedBookData><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29999865</ArticleId></ArticleIdList></PubmedBookData></PubmedBookArticle></PubmedArticleSet>
